Summaries

AdobeStock_393558874

NICE guideline

NICE managing COVID-19 guideline

2022-06-27T09:16:00+01:00By

Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings

tutye hands gloves ppe

PHE/DH/DWP guideline

UKHSA IPC for seasonal respiratory infections guideline

2022-05-04T09:45:00+01:00By UK Health Security Agency, DHSC, Public Health Wales, Public Health Agency Northern Ireland, NHS National Services Scotland, NHS England

Covering the infection prevention and control principles required to prevent transmission of COVID-19 and other respiratory viruses for winter 2021–2022

Maridav cough doctor sneeze staff covid

PHE/DH/DWP guideline

UKHSA staff with symptoms of a respiratory infection guideline

2022-04-12T10:42:00+01:00By UK Health Security Agency

Covering the management of healthcare staff with symptoms of a respiratory infection, including COVID-19 and positive COVID-19 test results

Syringe with vaccine_AS resized

PHE/DH/DWP guideline

UKHSA COVID-19 vaccination guidance

2022-03-22T08:30:00+00:00By UK Health Security Agency

A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme

AdobeStock_329035023

NICE guideline

NICE ‘long COVID’ guideline

2021-11-12T16:56:00+00:00By , , Royal College of General Practitioners

Recommendations for identifying and managing ‘long-COVID’ in primary care

AdobeStock_292279272

NICE guideline

COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response

2021-04-13T13:57:00+01:00By

A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic

AdobeStock_287082164

NICE guideline

COVID-19 rapid guideline on dermatological conditions

2021-04-13T13:49:00+01:00By

The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic

AdobeStock_162937550

NICE guideline

COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders

2021-04-09T15:27:00+01:00By

This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic

AdobeStock_319718852

NICE guideline

COVID-19 rapid guideline on systemic anticancer treatments

2021-02-18T11:53:00+00:00By

This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection

AdobeStock_133646819

Independent professional body guideline

HEART UK Managing hyperlipidaemia and COVID-19

2021-02-17T14:44:00+00:00By HEART UK

A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19

Pills + magnifying glass

NHS guideline

NHS guidance on NSAIDs in COVID-19

2020-06-26T12:57:00+01:00By NHS England

This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.

AdobeStock_332747243

NICE guideline

COVID-19 rapid guideline on COPD

2020-04-17T17:02:00+01:00By

The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.

AdobeStock_289304487

NICE guideline

COVID-19 rapid guideline on severe asthma

2020-04-17T13:39:00+01:00By

The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.